$AVIR.. BTA585 P2a: enrollment delayed, IND on clinical hold. IMO, dip likely to be bought w Vapendavir readout coming. (H/t @danwardbio) http://investors.aviragentherapeutics.com/releasedetail.cfm?ReleaseID=973105